In nearly every executive search conversation I have with founders, CEOs, and board members in Life Sciences, there is an understandable instinct that surfaces early. “We already know who we would hire.”
It is rarely said with arrogance. More often it is said with confidence. These are experienced operators. They have built companies, raised capital, and exited successfully. Their networks are deep. Their investors are well connected. The ecosystem is tight. There is real strength in that.
Continue reading “Is Our Short List a Reflection of Comfort or of the Market?”










When Facebook announced its name change to Meta in October 2021, the idea of a metaverse became a reality for millions of people who had never heard of the term before. Tech experts on the other hand were revelling in the growing interest in the virtual world. While Meta is just one way that a company is harnessing the metaverse for a social media reason there are many others that can see a future for life sciences online, utilizing this new power to improve outcomes. We took a look at how the metaverse could work to improve access to clinical trials and ensure a more diverse population takes part.




